Total planned funding: $658,413,340
Clear active filters
Treatment
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $141,310,913 |
| Uganda | $105,861,834 |
| Zambia | $71,449,130 |
| Kenya | $70,809,100 |
| Côte d'Ivoire | $56,724,585 |
| Mozambique | $52,924,667 |
| South Africa | $35,340,572 |
| Zimbabwe | $30,217,643 |
| Vietnam | $24,000,000 |
| Tanzania | $20,029,152 |
| Rwanda | $17,768,717 |
| Haiti | $12,525,849 |
| Botswana | $10,366,983 |
| Ethiopia | $3,789,606 |
| Guyana | $2,761,954 |
| Eswatini | $1,248,694 |
| Namibia | $939,798 |
| Dominican Republic | $148,986 |
| Burundi | $100,000 |
| Cambodia | $50,217 |
| Ukraine | $25,824 |
| Democratic Republic of the Congo | $19,116 |
Organizational Types
| Private Contractor | $512,010,793 |
| NGO | $83,802,103 |
| Implementing Agency | $24,763,040 |
| Unknown | $22,020,544 |
| Host Country Government Agency | $6,778,424 |
| FBO | $3,518,995 |
| University | $3,364,340 |
| Parastatal | $1,073,626 |
| Other USG Agency | $569,897 |
| Own Agency | $511,578 |
Program Areas
| Treatment | $658,413,340 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $658,413,340 |
Top Partner Programs
Management Sciences for Health:
$18,954,999
View countries